Healthcare Equipment & Supplies industry

2 companies · ₹1,361 cr · 1 with AI deep dives · Q1FY27 report

Exhibit 3Structure

₹1,361 cr

Avience Biomedicals Ltd is 90.3% of this industry by market cap. The top 5 are 100% and the top 10 are 100%.

small 1micro 11 above ₹500 cr

Exhibit 5Coverage (2 of 2)

Every company here with a deep dive, topped up by market cap. The rest of the industry is in the appendix.

Company	Mcap	P/E	EV/EBITDA	ROCE	Margin	Rev YoY	Read
Avience Biomedicals Ltd	₹148 cr	11.9x	11.6x	23.2%	28.4%	-	Unlock
Q-Line Biotech Ltd	₹1,264 cr	17.5x	14.5x	19.7%	28.7%	-	Unlock

Avience Biomedicals Ltd

Mcap: ₹148 cr
P/E: 11.9x
EV/EBITDA: 11.6x
ROCE: 23.2%
Margin: 28.4%
Rev YoY: -

Unlock

Q-Line Biotech Ltd

Mcap: ₹1,264 cr
P/E: 17.5x
EV/EBITDA: 14.5x
ROCE: 19.7%

Exhibit 6What managements said

from this industry's latest earnings calls · as of 2026-06-30

headwindWest Asia shipping freeze stranding export orders across device, consumable, and equipment names3 managements

Three independent managements described an ongoing West Asia shipping disruption as a live revenue constraint. Poly Medicure cited unavailable containers and ships not calling at…

POLYMED (Q1FY27): “shipping schedule is still disrupted for Middle East, and it's still hard to find…”

tailwind4 managements headwind2 managements

Exhibit 7Outlook

The outlook and what resolves next quarter

Where these managements said things are heading, and the dated, checkable events that would change it. Free with an account - 3 full reports a quarter.

Create a free account →

AppendixThe other 0 companies

1-0

sort: mcap · composite · name